KLINIQ.BK SET
The Klinique Medical Clinic Public Company Limited
1W: +0.9%
1M: -2.6%
3M: +8.8%
YTD: +17.1%
1Y: +14.9%
3Y: -19.0%
฿27.75 ($0.83)
+0.50 (+1.83%)
Weekly Expected Move ±3.7%
฿26
฿27
฿28
฿29
฿30
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$3.5B
+11.5% ▲
5Y CAGR: +35.1%
Total Liabilities
$1.7B
+21.1% ▲
5Y CAGR: +20.7%
Shareholders Equity
$1.8B
+3.3% ▲
5Y CAGR: +74.0%
Cash & Investments
$717M
-7.9% ▼
5Y CAGR: +138.6%
Total Debt
$1.2B
+52.2% ▲
5Y CAGR: +41.9%
Net Debt
$909M
+63.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $76M | $464M | $108M | $248M | $315M |
| Short-Term Investments | $0 | $1.0B | $1.1B | $531M | $403M |
| Cash & ST Investments | $76M | $1.5B | $1.2B | $779M | $717M |
| Net Receivables | $35M | $53M | $12M | $48M | $13M |
| Inventory | $84M | $120M | $191M | $272M | $385M |
| Other Current Assets | $2M | $22M | $35M | $16M | $41M |
| Total Current Assets | $202M | $1.7B | $1.5B | $1.1B | $1.2B |
| Property, Plant & Equip. | $534M | $818M | $1.2B | $1.8B | $1.9B |
| Goodwill & Intangibles | $2M | $4M | $4M | $5M | $4M |
| Long-Term Investments | $5M | $5M | $100K | $15M | $31M |
| Other Non-Current Assets | $70M | $82M | $149M | $149M | $219M |
| Total Non-Current Assets | $622M | $913M | $1.4B | $2.0B | $2.3B |
| Total Assets | $825M | $2.6B | $2.8B | $3.1B | $3.5B |
| — Liabilities — | |||||
| Accounts Payable | $33M | $63M | $89M | $117M | $152M |
| Short-Term Debt | $0 | $0 | $0 | $146M | $163M |
| Deferred Revenue | $289M | $403M | $401M | $406M | $466M |
| Other Current Liabilities | $6M | $9M | $11M | -$39M | $154M |
| Total Current Liabilities | $499M | $705M | $766M | $865M | $1.0B |
| Long-Term Debt | $0 | $0 | $0 | $0 | $530M |
| Other Non-Current Liab. | $15M | $5M | $6M | $6M | -$523M |
| Total Non-Current Liabilities | $165M | $239M | $377M | $536M | $676M |
| Total Liabilities | $664M | $944M | $1.1B | $1.4B | $1.7B |
| — Equity — | |||||
| Common Stock | $80M | $110M | $110M | $110M | $110M |
| Retained Earnings | $68M | $121M | $167M | $192M | $237M |
| Accumulated OCI | $11M | $11M | $11M | $11M | $11M |
| Total Stockholders Equity | $161M | $1.6B | $1.7B | $1.7B | $1.8B |
| Total Liabilities & Equity | $825M | $2.6B | $2.8B | $3.1B | $3.5B |
| — Key Metrics — | |||||
| Total Debt | $207M | $305M | $461M | $804M | $1.2B |
| Net Debt | $131M | -$159M | $353M | $556M | $909M |
| Total Investments | $5M | $1.0B | $1.1B | $546M | $434M |